|
DE3508258A1
(de)
*
|
1985-03-08 |
1986-09-18 |
Bayer Ag, 5090 Leverkusen |
Ss-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln
|
|
FR2643903A1
(fr)
|
1989-03-03 |
1990-09-07 |
Union Pharma Scient Appl |
Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux
|
|
RU1836357C
(ru)
|
1990-07-23 |
1993-08-23 |
Др.Карл Томэ ГмбХ |
Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
|
|
DE4023369A1
(de)
|
1990-07-23 |
1992-01-30 |
Thomae Gmbh Dr K |
Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
DE4225756A1
(de)
|
1992-01-22 |
1994-03-10 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
SI9210098B
(sl)
|
1991-02-06 |
2000-06-30 |
Dr. Karl Thomae |
Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
|
|
DE4224752A1
(de)
|
1992-04-11 |
1994-02-03 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
US5614519A
(en)
|
1991-02-06 |
1997-03-25 |
Karl Thomae Gmbh |
(1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
|
|
US5125961A
(en)
|
1991-08-12 |
1992-06-30 |
Monsanto Company |
Substituted pyridine compounds
|
|
DE4219534A1
(de)
|
1992-02-19 |
1993-12-16 |
Thomae Gmbh Dr K |
Substituierte Biphenylylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
DE4408497A1
(de)
|
1994-03-14 |
1995-09-21 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
EP0804434A1
(en)
|
1994-08-02 |
1997-11-05 |
MERCK SHARP & DOHME LTD. |
Azetidine, pyrrolidine and piperidine derivatives
|
|
CA2218493C
(en)
|
1995-04-21 |
2005-02-22 |
Neurosearch A/S |
Benzimidazole compounds and their use as modulators of the gabaa receptor complex
|
|
JP2000072675A
(ja)
|
1998-08-26 |
2000-03-07 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
|
EP1144387A1
(en)
|
1998-12-04 |
2001-10-17 |
Neurosearch A/S |
New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
|
|
US6380235B1
(en)
|
1999-05-04 |
2002-04-30 |
American Home Products Corporation |
Benzimidazolones and analogues
|
|
US6664252B2
(en)
|
1999-12-02 |
2003-12-16 |
Osi Pharmaceuticals, Inc. |
4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
|
|
GB0002100D0
(en)
|
2000-01-28 |
2000-03-22 |
Novartis Ag |
Organic compounds
|
|
AU2001234705A1
(en)
|
2000-02-01 |
2001-08-14 |
Cor Therapeutics, Inc. |
Indalone and benzimidazolone inhibitors of factor xa
|
|
US20120028912A1
(en)
|
2000-02-22 |
2012-02-02 |
J.David Gladstone Institute |
Methods of modulating bromodomains
|
|
AU2001297622A1
(en)
|
2000-10-27 |
2002-09-12 |
Dow Agrosciences Llc |
Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
|
|
BR0115847A
(pt)
*
|
2000-12-01 |
2004-02-25 |
Osi Pharm Inc |
Compostos especìficos para receptor para adenosina a1, a2a, e a3 e usos dos mesmos
|
|
CN1659143A
(zh)
|
2001-03-01 |
2005-08-24 |
盐野义制药株式会社 |
具有hiv整合酶抑制活性的含氮杂芳基化合物
|
|
WO2002072576A1
(en)
*
|
2001-03-09 |
2002-09-19 |
Pfizer Products Inc. |
Benzimidazole anti-inflammatory compounds
|
|
EP1370265B8
(en)
|
2001-03-15 |
2013-10-30 |
Janssen Pharmaceutica NV |
Hiv inhibiting pyrazinone derivatives
|
|
HN2002000067A
(es)
*
|
2001-03-23 |
2003-10-24 |
Bayer Healthcare Llc |
Inhibidores de la rho - quinasa.
|
|
US7081454B2
(en)
*
|
2001-03-28 |
2006-07-25 |
Bristol-Myers Squibb Co. |
Tyrosine kinase inhibitors
|
|
CA2442428A1
(en)
|
2001-03-28 |
2002-10-10 |
Mark D. Wittman |
Novel tyrosine kinase inhibitors
|
|
EP1475408B1
(en)
|
2002-02-15 |
2011-04-06 |
Bridgestone Corporation |
Rubber composition and pneumatic tire made therefrom
|
|
TWI276631B
(en)
|
2002-09-12 |
2007-03-21 |
Avanir Pharmaceuticals |
Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
|
|
US20040166137A1
(en)
|
2002-11-08 |
2004-08-26 |
Lackey John William |
Hetero-substituted benzimidazole compounds and antiviral uses thereof
|
|
AR043063A1
(es)
*
|
2002-12-13 |
2005-07-13 |
Altana Pharma Ag |
Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas
|
|
AR042956A1
(es)
|
2003-01-31 |
2005-07-13 |
Vertex Pharma |
Inhibidores de girasa y usos de los mismos
|
|
CL2004000409A1
(es)
*
|
2003-03-03 |
2005-01-07 |
Vertex Pharma |
Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
|
|
WO2004098494A2
(en)
|
2003-04-30 |
2004-11-18 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
AU2003902860A0
(en)
|
2003-06-06 |
2003-06-26 |
Daicel Chemical Industries, Ltd |
Benzimidazole compounds
|
|
WO2005013950A2
(en)
|
2003-08-08 |
2005-02-17 |
Avanir Pharmaceuticals |
Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
|
|
CL2004002050A1
(es)
|
2003-08-13 |
2005-06-03 |
Pharmacia Corp Sa Organizada B |
Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
|
|
US7863310B2
(en)
|
2004-02-03 |
2011-01-04 |
Eli Lilly And Company |
Kinase inhibitors
|
|
WO2005075432A1
(ja)
|
2004-02-06 |
2005-08-18 |
Chugai Seiyaku Kabushiki Kaisha |
１−（２ｈ）−イソキノロン誘導体およびその抗ガン剤としての使用
|
|
CN1285590C
(zh)
|
2004-02-23 |
2006-11-22 |
上海医药工业研究院 |
伊曲康唑盐酸盐口服固体组合物和制备方法
|
|
EP1730120A1
(en)
|
2004-03-23 |
2006-12-13 |
F.Hoffmann-La Roche Ag |
Non-nucleoside reverse transcriptase inhibitors
|
|
EP1734820A4
(en)
|
2004-04-16 |
2008-01-23 |
Neurogen Corp |
Imidazopyrrazine, imidazopyridine, and imidazo-pyrimidine as CRF1 receptor ligands
|
|
WO2005117876A1
(en)
|
2004-06-01 |
2005-12-15 |
University Of Virginia Patent Foundation |
Dual small molecule inhibitors of cancer and angiogenesis
|
|
WO2005121132A1
(ja)
|
2004-06-11 |
2005-12-22 |
Shionogi & Co., Ltd. |
抗ｈｃｖ作用を有する縮合ヘテロ環化合物
|
|
EP1786777A1
(en)
|
2004-08-26 |
2007-05-23 |
Pfizer, Inc. |
Aminoheteroaryl compounds as protein tyrosine kinase inhibitors
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
WO2006038734A1
(en)
|
2004-10-08 |
2006-04-13 |
Astellas Pharma Inc. |
Pyridazinone derivatives cytokines inhibitors
|
|
US7846915B2
(en)
|
2004-10-20 |
2010-12-07 |
Resverlogix Corporation |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
|
WO2006084281A1
(en)
|
2005-02-04 |
2006-08-10 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of e1 activating enzymes
|
|
US20060223849A1
(en)
*
|
2005-03-14 |
2006-10-05 |
Mjalli Adnan M |
Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
|
|
EP1881966A2
(en)
|
2005-05-03 |
2008-01-30 |
Dow AgroSciences LLC |
Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-trianzin-6-ones, and their use as fungicides
|
|
WO2007016525A2
(en)
|
2005-07-29 |
2007-02-08 |
Resverlogix Corp. |
Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
|
|
WO2007040208A1
(ja)
|
2005-10-03 |
2007-04-12 |
Ono Pharmaceutical Co., Ltd. |
含窒素複素環化合物およびその医薬用途
|
|
WO2007061923A2
(en)
|
2005-11-18 |
2007-05-31 |
Takeda San Diego, Inc. |
Glucokinase activators
|
|
DE602006011363D1
(de)
*
|
2005-12-01 |
2010-02-04 |
Hoffmann La Roche |
Heteroaryl-substituierte piperidin-derivate als l-cpt1-hemmer
|
|
CN101384593A
(zh)
*
|
2006-02-17 |
2009-03-11 |
辉瑞有限公司 |
用作tlr7调节剂的3-脱氮嘌呤衍生物
|
|
AU2007216247A1
(en)
*
|
2006-02-17 |
2007-08-23 |
Pfizer Limited |
3 -deazapurine derivatives as TLR7 modulators
|
|
US8008481B2
(en)
*
|
2006-03-31 |
2011-08-30 |
Ericsson Anna M |
Indazole compounds
|
|
EA200870404A1
(ru)
|
2006-04-03 |
2009-04-28 |
Глэксо Груп Лимитед |
Производные азабицикло[3.1.0.]гексила в качестве модуляторов рецепторов допамина d3
|
|
CA2700988A1
(en)
|
2006-09-27 |
2008-05-08 |
Surface Logix, Inc. |
Rho kinase inhibitors
|
|
EP2094662B1
(en)
|
2006-12-14 |
2012-04-11 |
Astellas Pharma Inc. |
Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents
|
|
SG144809A1
(en)
*
|
2007-01-11 |
2008-08-28 |
Millipore U K Ltd |
Benzimidazole compounds and their use as chromatographic ligands
|
|
PT2118074E
(pt)
|
2007-02-01 |
2014-03-20 |
Resverlogix Corp |
Compostos para a prevenção e tratamento de doenças cardiovasculares
|
|
WO2008153701A1
(en)
|
2007-05-24 |
2008-12-18 |
Schering Corporation |
Compounds for inhibiting ksp kinesin activity
|
|
CN101790526A
(zh)
*
|
2007-06-08 |
2010-07-28 |
雅培制药有限公司 |
用作激酶抑制剂的5-杂芳基取代的吲唑化合物
|
|
WO2009000413A1
(en)
|
2007-06-26 |
2008-12-31 |
Sanofi-Aventis |
A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
|
|
DE102007032507A1
(de)
|
2007-07-12 |
2009-04-02 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
DE102007038957A1
(de)
|
2007-08-17 |
2009-02-19 |
Merck Patent Gmbh |
6-Thioxo-pyridazinderivate
|
|
GB0719235D0
(en)
|
2007-10-02 |
2007-11-14 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2009054790A1
(en)
|
2007-10-26 |
2009-04-30 |
Astrazeneca Ab |
Amide linked heteroaromatic derivatives as modulators of mglur5
|
|
CA2708262A1
(en)
|
2007-12-07 |
2009-06-18 |
Elan Pharmaceuticals, Inc. |
Methods and compositions for treating liquid tumors
|
|
US8084466B2
(en)
|
2007-12-18 |
2011-12-27 |
Janssen Pharmaceutica Nv |
Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptor
|
|
CN101910182B
(zh)
|
2007-12-28 |
2013-07-17 |
田边三菱制药株式会社 |
抗癌剂
|
|
TW200942537A
(en)
*
|
2008-02-01 |
2009-10-16 |
Irm Llc |
Compounds and compositions as kinase inhibitors
|
|
WO2009158258A1
(en)
|
2008-06-25 |
2009-12-30 |
E. I. Du Pont De Nemours And Company |
Herbicidal dihydro oxo six-membered azinyl isoxazolines
|
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
|
US9540322B2
(en)
*
|
2008-08-18 |
2017-01-10 |
Yale University |
MIF modulators
|
|
MX2011001872A
(es)
*
|
2008-08-18 |
2011-05-23 |
Univ Yale |
Moduladores de mif.
|
|
CN102264743B
(zh)
|
2008-11-25 |
2015-02-11 |
罗彻斯特大学 |
Mlk抑制剂及其使用方法
|
|
PT2370413E
(pt)
|
2008-12-08 |
2015-10-23 |
Arena Pharm Inc |
Moduladores do recetor da prostaciclina (pgi2) úteis para o tratamento de distúrbios relacionados com o mesmo
|
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
|
DE102008062826A1
(de)
|
2008-12-23 |
2010-07-01 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
US8389550B2
(en)
|
2009-02-25 |
2013-03-05 |
Hoffmann-La Roche Inc. |
Isoxazoles / O-pyridines with ethyl and ethenyl linker
|
|
MX2011009568A
(es)
|
2009-03-09 |
2011-12-06 |
Surface Logix Inc |
Inhibidores de la rho cinasa.
|
|
NZ617779A
(en)
|
2009-03-18 |
2015-08-28 |
Resverlogix Corp |
Novel anti-inflammatory agents
|
|
CN102448458B
(zh)
|
2009-03-18 |
2015-07-22 |
小利兰·斯坦福大学理事会 |
治疗黄病毒科病毒感染的方法和组合物
|
|
US9757368B2
(en)
|
2009-04-22 |
2017-09-12 |
Resverlogix Corp. |
Anti-inflammatory agents
|
|
US8415379B2
(en)
|
2009-05-05 |
2013-04-09 |
Hoffmann-La Roche Inc. |
Pyridines
|
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
GB0919423D0
(en)
*
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
CA2779355C
(en)
|
2009-11-05 |
2018-01-16 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
|
AU2010317096B2
(en)
|
2009-11-05 |
2015-03-26 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
JP5757956B2
(ja)
|
2009-11-20 |
2015-08-05 |
エスケー ケミカルス シーオー．， エルティーディー．Ｓｋ Ｃｈｅｍｉｃａｌｓ Ｃｏ．， Ｌｔｄ． |
ゴナドトロピン放出ホルモン受容体拮抗剤、その製造方法及びそれを含む医薬組成物
|
|
EP2507231A1
(en)
*
|
2009-12-03 |
2012-10-10 |
Glaxo Group Limited |
Indazole derivatives as pi 3 - kinase inhibitors
|
|
WO2011097607A1
(en)
|
2010-02-08 |
2011-08-11 |
Southern Research Institute |
Anti-viral treatment and assay to screen for anti-viral agent
|
|
KR101165996B1
(ko)
|
2010-04-23 |
2012-07-18 |
주식회사 녹십자 |
프탈라지논 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
|
|
ES2606958T3
(es)
|
2010-05-14 |
2017-03-28 |
Dana-Farber Cancer Institute, Inc. |
Compuestos de tienotriazolodiazepina para tratar una neoplasia
|
|
JP2011246389A
(ja)
*
|
2010-05-26 |
2011-12-08 |
Oncotherapy Science Ltd |
Ｔｔｋ阻害作用を有する縮環ピラゾール誘導体
|
|
US8933096B2
(en)
|
2010-06-09 |
2015-01-13 |
Rugers, The State University of New Jersey |
Antimicrobial agents
|
|
WO2011159926A1
(en)
|
2010-06-16 |
2011-12-22 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
CA2803448A1
(en)
|
2010-07-06 |
2012-01-12 |
Universite De Montreal |
Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators
|
|
WO2012009258A2
(en)
|
2010-07-13 |
2012-01-19 |
Edward Roberts |
Peptidomimetic galanin receptor modulators
|
|
EP2603079B1
(en)
|
2010-08-12 |
2018-09-19 |
Merck Sharp & Dohme Corp. |
Positive allosteric modulators of mglur2
|
|
WO2012040499A2
(en)
|
2010-09-22 |
2012-03-29 |
Surface Logix, Inc. |
Metabolic inhibitors
|
|
KR101242572B1
(ko)
|
2010-10-12 |
2013-03-19 |
한국화학연구원 |
5-환 헤테로 아릴로 치환된 프탈라지논 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 약학적 조성물
|
|
GB201018147D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Method of treatment
|
|
WO2012075456A1
(en)
|
2010-12-02 |
2012-06-07 |
Constellation Pharmaceuticals |
Bromodomain inhibitors and uses thereof
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
CN102731409A
(zh)
|
2011-04-08 |
2012-10-17 |
中国科学院上海药物研究所 |
一类哒嗪酮类化合物，其药物组合物、制备方法及用途
|
|
GB201106750D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106743D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106799D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201107325D0
(en)
|
2011-05-04 |
2011-06-15 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2012174487A2
(en)
*
|
2011-06-17 |
2012-12-20 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
GB201114103D0
(en)
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2013027168A1
(en)
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
WO2013047813A1
(ja)
*
|
2011-09-30 |
2013-04-04 |
大鵬薬品工業株式会社 |
１，２，４－トリアジン－６－カルボキサミド誘導体
|
|
PT2773354T
(pt)
|
2011-11-01 |
2019-07-17 |
Resverlogix Corp |
Formulações orais de libertação imediata para quinazolinonas substituídas
|
|
KR102031846B1
(ko)
|
2011-12-01 |
2019-10-14 |
케모센트릭스, 인크. |
Ｃｃｒ(4) 길항제로서의 치환된 벤즈이미다졸 및 벤조피라졸
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
US20130281398A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281399A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281396A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281397A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
WO2013155695A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbott Laboratories |
Isoindolone derivatives
|
|
WO2013184878A1
(en)
|
2012-06-06 |
2013-12-12 |
Constellation Pharmaceuticals, Inc. |
Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
CA2874303C
(en)
|
2012-06-11 |
2020-10-13 |
Ucb Biopharma Sprl |
Tnf -alpha modulating benz imidazoles
|
|
WO2014031928A2
(en)
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Heterocyclic modulators of hif activity for treatment of disease
|
|
WO2014037340A1
(de)
|
2012-09-05 |
2014-03-13 |
Bayer Cropscience Ag |
Verwendung substituierter 2-amidobenzimidazole, 2-amidobenzoxazole und 2-amidobenzothiazole oder deren salze als wirkstoffe gegen abiotischen pflanzenstress
|
|
WO2014043246A1
(en)
|
2012-09-11 |
2014-03-20 |
The Board Of Trustees Of The University Of Illinois |
Enoyl reductase inhibitors with antibacterial activity
|
|
US9663533B2
(en)
|
2012-11-14 |
2017-05-30 |
Glaxosmithkline Llc |
Thieno[3,2-C]pyridin-4(5H)-ones as BET inhibitors
|
|
US9765039B2
(en)
|
2012-11-21 |
2017-09-19 |
Zenith Epigenetics Ltd. |
Biaryl derivatives as bromodomain inhibitors
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
HK1211033A1
(en)
|
2012-12-20 |
2016-05-13 |
Bayer Pharma Aktiengesellschaft |
Bet-protein-inhibiting dihydroquinoxalinones
|
|
JP2016507496A
(ja)
|
2012-12-21 |
2016-03-10 |
ゼニス・エピジェネティクス・コーポレイションＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｃｏｒｐ． |
ブロモドメイン阻害剤としての新規複素環式化合物
|
|
HK1212972A1
(zh)
|
2013-02-22 |
2016-06-24 |
Bayer Pharma Aktiengesellschaft |
作爲bet-蛋白抑制剂用於治疗过度增殖性疾病的吡咯并-和吡唑并-三唑并二氮杂卓
|
|
CA2901805A1
(en)
|
2013-02-22 |
2014-08-28 |
Bayer Pharma Aktiengesellschaft |
4-substituted pyrrolo- and pyrazolo-diazepines
|
|
WO2014128655A1
(en)
|
2013-02-25 |
2014-08-28 |
Aurigene Discovery Technologies Limited |
Substituted imidazo[4,5-c]quinoline derivatives as bromodomain inhibitors
|
|
US9492460B2
(en)
|
2013-02-27 |
2016-11-15 |
Bristol-Myers Squibb Company |
Carbazole compounds useful as bromodomain inhibitors
|
|
EP2961747B1
(en)
|
2013-02-27 |
2017-11-15 |
Bristol-Myers Squibb Company |
Carbazole compounds useful as bromodomain inhibitors
|
|
EP2970285B1
(en)
|
2013-03-11 |
2019-04-17 |
AbbVie Inc. |
Fused tetracyclic bromodomain inhibitors
|
|
BR112015022861A8
(pt)
|
2013-03-11 |
2019-11-26 |
Abbvie Inc |
inibidores de bromodomínio
|
|
EP2970312B1
(en)
|
2013-03-11 |
2017-11-15 |
The Regents of The University of Michigan |
Bet bromodomain inhibitors and therapeutic methods using the same
|
|
CN105164113B
(zh)
|
2013-03-12 |
2018-03-02 |
艾伯维公司 |
吡咯酰胺抑制剂
|
|
JP2016512543A
(ja)
|
2013-03-12 |
2016-04-28 |
アッヴィ・インコーポレイテッド |
ジヒドロ−ピロロピリジノンブロモドメイン阻害剤
|
|
CN105189461B
(zh)
|
2013-03-14 |
2018-05-15 |
葛兰素史克知识产权第二有限公司 |
2,3-二取代的1-酰基-4-氨基-1,2,3,4-四氢喹啉衍生物和它们作为溴结构域抑制剂的用途
|
|
US9670221B2
(en)
|
2013-03-14 |
2017-06-06 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Furopyridines as bromodomain inhibitors
|
|
EA201591746A1
(ru)
|
2013-03-14 |
2016-08-31 |
КОНВЕРДЖЕН ЭлЭлСи |
Способы и композиции для ингибирования бромодомен-содержащих белков
|
|
US20140303121A1
(en)
|
2013-03-15 |
2014-10-09 |
Plexxikon Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2014152029A2
(en)
|
2013-03-15 |
2014-09-25 |
Epigenetix, Inc. |
Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
|
|
CN105073747B
(zh)
|
2013-03-15 |
2017-06-06 |
普莱希科公司 |
杂环化合物及其应用
|
|
EA035469B1
(ru)
|
2013-03-15 |
2020-06-22 |
Инсайт Холдингс Корпорейшн |
Трициклические гетероциклы как ингибиторы белков бэт
|
|
US9199988B2
(en)
|
2013-03-27 |
2015-12-01 |
Boehringer Ingelheim International Gmbh |
Dihydroquinazolinone analogues
|
|
EP2978757B1
(en)
|
2013-03-27 |
2017-02-08 |
Boehringer Ingelheim International GmbH |
Indolinone analogues as brd4 inhibitors
|
|
TWI530499B
(zh)
|
2013-03-28 |
2016-04-21 |
吉李德科學股份有限公司 |
作為溴結構域（ｂｒｏｍｏｄｏｍａｉｎ）抑制劑之苯並咪唑酮衍生物類
|
|
EP2792355A1
(en)
|
2013-04-17 |
2014-10-22 |
Albert-Ludwigs-Universität Freiburg |
Compounds for use as bromodomain inhibitors
|
|
EP2996689A1
(en)
|
2013-04-17 |
2016-03-23 |
Albert-Ludwigs-Universität Freiburg |
Compounds for use as bromodomain inhibitors
|
|
EA027139B1
(ru)
|
2013-04-26 |
2017-06-30 |
Бейджин, Лтд. |
Замещенные 5-(3,5-диметилизоксазол-4-ил)индолин-2-оны
|
|
TWI527811B
(zh)
*
|
2013-05-09 |
2016-04-01 |
吉李德科學股份有限公司 |
作爲溴結構域抑制劑的苯並咪唑衍生物
|
|
US8975417B2
(en)
|
2013-05-27 |
2015-03-10 |
Novartis Ag |
Pyrazolopyrrolidine derivatives and their use in the treatment of disease
|
|
CN105209467B
(zh)
|
2013-05-27 |
2018-06-08 |
诺华股份有限公司 |
咪唑并吡咯烷酮衍生物及其在治疗疾病中的用途
|
|
CA2915419A1
(en)
|
2013-06-17 |
2014-12-24 |
Bayer Pharma Aktiengesellschaft |
Substituted phenyl-2,3-benzodiazepines
|
|
CN105473581B
(zh)
|
2013-06-21 |
2019-04-23 |
齐尼思表观遗传学有限公司 |
作为溴结构域抑制剂的新取代的双环化合物
|
|
KR102307566B1
(ko)
|
2013-06-21 |
2021-10-05 |
제니쓰 에피제네틱스 리미티드 |
신규한 바이사이클릭 브로모도메인 억제제
|
|
AR096758A1
(es)
|
2013-06-28 |
2016-02-03 |
Abbvie Inc |
Inhibidores cristalinos de bromodominios
|
|
EP3019502B1
(en)
|
2013-07-08 |
2017-05-17 |
Incyte Holdings Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
|
WO2015011084A1
(de)
|
2013-07-23 |
2015-01-29 |
Bayer Pharma Aktiengesellschaft |
Substituierte dihydropyrido[3,4-b]pyrazinone als duale inhibitoren von bet-proteinen und polo-like kinasen
|
|
BR112016001457A2
(pt)
|
2013-07-25 |
2017-08-29 |
Dana Farber Cancer Inst Inc |
Inibidores de fatores de transcrição e usos dos mesmos
|
|
CA2919948C
(en)
|
2013-07-31 |
2020-07-21 |
Zenith Epigenetics Corp. |
Novel quinazolinones as bromodomain inhibitors
|
|
US20150051208A1
(en)
|
2013-08-14 |
2015-02-19 |
Boehringer Ingelheim International Gmbh |
Pyridinones
|
|
RU2720237C2
(ru)
|
2013-11-18 |
2020-04-28 |
Форма Терапеутикс, Инк. |
Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
|
|
BR122019007990B1
(pt)
|
2013-11-18 |
2021-05-04 |
Forma Therapeutics, Inc |
Composto, e, composição farmacêutica
|
|
GB201321739D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
US9458156B2
(en)
|
2014-12-23 |
2016-10-04 |
Bristol-Myers Squibb Company |
Tricyclic compounds as anticancer agents
|
|
US10179125B2
(en)
|
2014-12-01 |
2019-01-15 |
Zenith Epigenetics Ltd. |
Substituted pyridines as bromodomain inhibitors
|
|
HK1245246A1
(zh)
|
2014-12-01 |
2018-08-24 |
恒翼生物医药科技(上海)有限公司 |
作为溴域抑制剂的取代吡啶酮
|
|
WO2016092375A1
(en)
|
2014-12-11 |
2016-06-16 |
Zenith Epigenetics Corp. |
Substituted heterocycles as bromodomain inhibitors
|
|
CN107406438B
(zh)
|
2014-12-17 |
2021-05-14 |
恒翼生物医药科技(上海)有限公司 |
溴结构域的抑制剂
|
|
CA2966452A1
(en)
|
2014-12-17 |
2016-06-23 |
Samuel David Brown |
Substituted bicyclic compounds as bromodomain inhibitors
|